Insight Molecular Diagnostics Inc. (IMDX) › Total AssetsInsight Molecular Diagnostics Inc. (IMDX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $12.73M2016: $14.45M2017: $10.22M2018: $9.52M2019: $39.86M2020: $55.42M2021: $159.56M2022: $100.09M2023: $74.89M2024: $35.08M2025: $25.76M$25.76M2015Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$25.76M-26.6%2024$35.08M-53.2%2023$74.89M-25.2%2022$100.09M-37.3%2021$159.56M+187.9%2020$55.42M+39.0%2019$39.86M+318.8%2018$9.52M-6.8%2017$10.22M-29.3%2016$14.45M+13.5%2015$12.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share